Tyvaso COPD PII - Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia"
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
June 25, 2025
End Date
May 18, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
June 25, 2025
End Date
May 18, 2030